(Q40056028)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Xiaoying He

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Yun Liao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Wen Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Huan Tong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jieqi Ke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Xiaoping Wan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

27 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

9951-9958

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815505%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-016-4869-5

6 March 2020

exact match

0 references

cites work

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Markers for individualised therapy in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

The role of stathmin in the regulation of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Stathmin 1: a novel therapeutic target for anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

PAK4 is activated via PI3K in HGF-stimulated epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4869-5

Stathmin is a potential molecular marker and target for the treatment of gastric cancer.

21 January 2018

1 reference

12 December 2020

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer

1 reference

12 December 2020

The relationships between the immunoexpression of KAI1, MMP-2, MMP-9 and steroid receptors expression in endometrial cancer

1 reference

12 December 2020

Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion

1 reference

12 December 2020

Adjuvant chemotherapy for advanced endometrial cancer

1 reference

12 December 2020